Search Results - "Krolewski, John"
-
1
Opportunities and challenges in combination gene cancer therapy
Published in Advanced drug delivery reviews (01-03-2016)“…Treatment for solid tumor malignancies, which constitute the majority of human cancers, is still dominated by surgery and radiotherapies. This is especially…”
Get full text
Journal Article -
2
Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma
Published in Journal of experimental & clinical cancer research (12-08-2021)“…The incidence of renal cell carcinoma (RCC) is increasing worldwide with an approximate 20% mortality rate. The challenge in RCC is the therapy-resistance…”
Get full text
Journal Article -
3
MicroRNA-141 suppresses prostate cancer stem cells and metastasis by targeting a cohort of pro-metastasis genes
Published in Nature communications (23-01-2017)“…MicroRNAs play important roles in regulating tumour development, progression and metastasis. Here we show that one of the miR-200 family members, miR-141, is…”
Get full text
Journal Article -
4
Infiltrating Myeloid Cells Exert Protumorigenic Actions via Neutrophil Elastase
Published in Molecular cancer research (01-09-2017)“…Tissue infiltration and elevated peripheral circulation of granulocytic myeloid-derived cells is associated with poor outcomes in prostate cancer and other…”
Get full text
Journal Article -
5
Paternal lineage early onset hereditary ovarian cancers: A Familial Ovarian Cancer Registry study
Published in PLoS genetics (15-02-2018)“…Given prior evidence that an affected woman conveys a higher risk of ovarian cancer to her sister than to her mother, we hypothesized that there exists an…”
Get full text
Journal Article -
6
TGFβ Superfamily Members Mediate Androgen Deprivation Therapy-Induced Obese Frailty in Male Mice
Published in Endocrinology (Philadelphia) (01-11-2016)“…First line treatment for recurrent and metastatic prostate cancer is androgen deprivation therapy (ADT). Use of ADT has been increasing in frequency and…”
Get full text
Journal Article -
7
Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II-III Melanoma
Published in Clinical cancer research (15-04-2019)“…Biomarkers are needed to stratify patients with stage II-III melanoma for clinical trials of adjuvant therapy because, while immunotherapy is protective, it…”
Get full text
Journal Article -
8
Infiltrated pre-adipocytes increase prostate cancer metastasis via modulation of the miR-301a/androgen receptor (AR)/TGF-β1/Smad/MMP9 signals
Published in Oncotarget (20-05-2015)“…High fat dietary intake may increase the risk of prostate cancer (PCa). Pre-adipocytes, one of the basic components in the tumor microenvironment (TME), are…”
Get full text
Journal Article -
9
TNF Signaling Is Required for Castration-Induced Vascular Damage Preceding Prostate Cancer Regression
Published in Cancers (07-12-2022)“…The mainstay treatment for locally advanced, recurrent, or metastatic prostate cancer (PrCa) is androgen deprivation therapy (ADT). ADT causes prostate cancers…”
Get full text
Journal Article -
10
Photoacoustic imaging with an acoustic lens detects prostate cancer cells labeled with PSMA-targeting near-infrared dye-conjugates
Published in Journal of biomedical optics (01-06-2016)“…There is an urgent need for sensitive and specific tools to accurately image early stage, organ-confined human prostate cancers to facilitate active…”
Get full text
Journal Article -
11
Loss of MAGEC3 Expression Is Associated with Prognosis in Advanced Ovarian Cancers
Published in Cancers (30-01-2022)“…Rare variants in MAGEC3 are associated with BRCA negative, early-onset ovarian cancers. Given this association, we evaluated the impact of MAGEC3 protein…”
Get full text
Journal Article -
12
Loss of PLZF expression in prostate cancer by immunohistochemistry correlates with tumor aggressiveness and metastasis
Published in PloS one (25-03-2015)“…PLZF is a transcription repressor, which plays a critical role in development, spermatogenesis and oncogenesis. Down-regulation of PLZF has been found in…”
Get full text
Journal Article -
13
TNF signaling mediates an enzalutamide-induced metastatic phenotype of prostate cancer and microenvironment cell co-cultures
Published in Oncotarget (22-09-2015)“…The dramatic responses tumors display to targeted therapies are limited by acquired or pre-existing mechanisms of therapy resistance. We recently discovered…”
Get full text
Journal Article -
14
TNF Is Necessary for Castration-Induced Prostate Regression, Whereas TRAIL and FasL Are Dispensable
Published in Molecular endocrinology (Baltimore, Md.) (01-04-2011)“…TNF is required for prostate regression and increases in a paracrine manner following castration; conversely, TRAIL and Fas are dispensable for this process…”
Get full text
Journal Article -
15
Phosphorylation and Specific Ubiquitin Acceptor Sites Are Required for Ubiquitination and Degradation of the IFNAR1 Subunit of Type I Interferon Receptor
Published in The Journal of biological chemistry (05-11-2004)“…Ubiquitination, endocytosis, and lysosomal degradation of the IFNAR1 (interferon α receptor 1) subunit of the type I interferon (IFN) receptor is mediated by…”
Get full text
Journal Article -
16
Quantitative volumetric imaging of normal, neoplastic and hyperplastic mouse prostate using ultrasound
Published in BMC urology (21-09-2015)“…Genetically engineered mouse models are essential to the investigation of the molecular mechanisms underlying human prostate pathology and the effects of…”
Get full text
Journal Article -
17
Correction: Infiltrated pre-adipocytes increase prostate cancer metastasis via modulation of the miR-301a/androgen receptor (AR)/TGF-β1/Smad/MMP9 signals
Published in Oncotarget (13-12-2016)Get full text
Journal Article -
18
Prostate tumor-derived GDF11 accelerates androgen deprivation therapy-induced sarcopenia
Published in JCI insight (26-03-2020)“…Most prostate cancers depend on androgens for growth, and therefore, the mainstay treatment for advanced, recurrent, or metastatic prostate cancer is androgen…”
Get full text
Journal Article -
19
Cytokine and growth factor receptors in the nucleus: What's up with that?
Published in Journal of cellular biochemistry (01-06-2005)“…Signaling via cell surface receptors that are anchored by a single transmembrane domain is a well‐established paradigm. Ligand binding to the extracellular…”
Get full text
Journal Article -
20
FLIP-ping out: Death receptor signaling in the prostate
Published in Cancer biology & therapy (01-08-2008)“…Prostate cancer is a leading cause of cancer related death. The growth of normal prostate epithelial cells is under the tight control of various growth…”
Get full text
Journal Article